The Latest: Deal to get 1.1B vaccines to over 190 nations
Share
Tweet
February 18, 2021
GAITHERSBURG, Md. — Vaccine developer Novavax has agreed to provide 1.1 billion doses of its experimental COVID-19 vaccine for use in more than 190 low- and middle-income countries.
The company said Thursday it has reached agreement with Gavi, the Vaccine Alliance, to provide the doses to the COVAX Facility, a project led by Gavi, the World Health Organization and the Coalition for Epidemic Preparedness Innovations.
They’re working with groups including UNICEF, the World Bank and charities to guarantee equitable access to vaccines against the coronavirus to all countries.
Novavax Inc., of Gait...
For access to this article please
sign in or
subscribe.
Reader Comments(0)